Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open-label Safety Study of FSME-IMMUN NEW in Healthy Children and Adolescents Aged 1 to 15 Years

NCT00161863 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT00161863
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00161863 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open-label Safety Study of FSME-IMMUN NEW in Healthy Children and Adolescents Aged 1 to 15 Years
Lead sponsor
Pfizer
Phase
Phase 3
Overall status
Completed
Start date
September 30, 2002
Completion date
January 31, 2003
Enrollment
Not reported
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

tick-borne encephalitis